Combo IVD Market Size is valued at USD 550.12 Mn in 2023 and is predicted to reach USD 920.86 Mn by the year 2031 at a 6.84% CAGR during the forecast period for 2024-2031.
Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are useful for detecting and monitoring a wide range of medical illnesses, including infectious disorders and autoimmune diseases. They are also sometimes used to look for changes in medication treatment. Growing numbers of people afflicted with infectious and chronic diseases are propelling the in vitro diagnostics industry forward. Modern workplaces are witnessing an alarming rising incidence of long-term health problems, including diabetes, cancer, heart disease, and tuberculosis. Infectious diseases, respiratory illnesses, and gastrointestinal issues have all seen significant increases in the number of people affected.
The increasing prevalence of these disorders is expected to fuel the demand for diagnostic equipment, which drives the IVD market. With better healthcare infrastructure, increased frequency of long-term health conditions, unmet healthcare needs, and the surge in demand for advanced in vitro diagnostic testing, the in vitro diagnostics market is anticipated to experience significant growth in untapped emerging markets. Furthermore, innovations in in vitro diagnostics are driving the market forward.
However, the market growth is hampered by the high-cost criteria for the safety and health of the combo IVD market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high combo IVD because of these equipment's high maintenance and operation costs. Professionals with the necessary training must also use in vitro diagnostic software. A further consequence is that the devices become more expensive to maintain, which slows down overall market expansion. The market for in-vitro diagnostics has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.
The combo IVD market is segmented based on test type, testing, end-user, channel, and sample type. According to test type segment, the market comprises SARS-CoV-2 Flu A/B Combo Test, COVID-19, Influenza A/B, RSV Combo test, COVID-19 IgM/IgG Combo Test, HIV-1/2 Ag/Ab Combo Test, HIV/Syphilis Ab Combo Test, HIV, HBsAg, HCV & Syphilis Combo, hCG Combo Test, Thrombophilia Detection Combo Test, and Other Test Types. Based on testing, the market is divided into rapid testing and point-of-care testing. By end-user segment, the market is categorised into diagnostic centres, hospitals, homecare settings, and other end-users. By channel, the market is segmented into over-the-counter and laboratory-based. By sample type, the market is segmented into oral and nasal swabs, human serum, whole blood, and other sample types.
The point-of-care testing combo IVD market is expected to hold a major global market share. The rapid generation of results at the point of care testing can increase clinical or economic outcomes, allowing for the implementation of appropriate treatment. By utilizing point-of-care testing, the interdisciplinary team is able to acquire the most current and accurate data, resulting in an improved and practical medical portrait.
In 2023, the hospital sector accounted for the highest proportion of income due to an increase in the number of hospitalizations that necessitate assistance from more efficient diagnostic methods. In addition, the ongoing growth of healthcare infrastructure and the positive actions taken by the government are expected to improve the current hospital facilities. This means that more people want IVD tests to be done in hospitals. Most IVD devices are bought and used by hospitals in large numbers.
The North American combo IVD market is expected to lead with the highest market revenue share in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system. In addition, Asia Pacific is projected to grow rapidly in the global combo IVD market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 550.12 Mn |
| Revenue Forecast In 2031 | USD 920.86 Mn |
| Growth Rate CAGR | CAGR of 6.84% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Test Type, By Testing, By End-User, By Channel, By Sample Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | DRG International Inc., Becton, Dickinson and Company, DiaCarta Inc, Abbott, bioMérieux SA4, Bio-Rad Laboratories, Alpha IVD Srl, BioGX BV, Thermo Fisher Scientific Inc., Megna Health Inc, CTK Biotech, Inc., Biopanda Reagents Ltd., F. Hoffmann-La Roche Ltd, Hologic Inc, Siemens AG and other prominent players. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Combo IVD Market Snapshot
Chapter 4. Global Combo IVD Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Sample Type Estimates & Trend Analysis
5.1. by Sample Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sample Type:
5.2.1. Orals and Nasal Swabs
5.2.2. Human Serum
5.2.3. Whole Blood
5.2.4. Other Sample Types
Chapter 6. Market Segmentation 2: by Channel Type Estimates & Trend Analysis
6.1. by Channel Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Channel Type:
6.2.1. Over-the-Counter
6.2.2. Laboratory based
Chapter 7. Market Segmentation 3: by Test Type Estimates & Trend Analysis
7.1. by Test Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Test Type:
7.2.1. SARS-CoV-2 Flu A/B Combo Test
7.2.2. COVID-19, Influenza A/B, RSV Combo test
7.2.3. COVID-19 IgM/IgG Combo Test
7.2.4. HIV-1/2 Ag/Ab Combo Test
7.2.5. HIV/Syphilis Ab Combo Test
7.2.6. HIV, HBsAg, HCV & Syphilis Combo
7.2.7. hCG Combo Test
7.2.8. Thrombophilia Detection Combo Test
7.2.9. Other Test Types
Chapter 8. Market Segmentation 4: by Testing Estimates & Trend Analysis
8.1. by Testing& Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Testing:
8.2.1. Rapid testing
8.2.2. Point of care testing
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User;
9.2.1. Diagnostics centres
9.2.2. Hospitals
9.2.3. Homecare setting
9.2.4. Other End-Users
Chapter 10. Combo IVD Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.1.2. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.1.3. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.1.4. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.1.5. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.2.2. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.2.3. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.2.4. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.2.5. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.3.2. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.3.3. Asia-Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.3.4. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.3.5. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
10.4. Latin America
10.4.1. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.4.2. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.4.3. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.4.4. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.4.5. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.5.2. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.5.3. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.5.4. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.5.5. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. DRG International Inc.
11.2.2. Becton, Dickinson and Company
11.2.3. DiaCarta Inc
11.2.4. Abbott
11.2.5. bioMérieux SA4
11.2.6. Bio-Rad Laboratories
11.2.7. Alpha IVD Srl
11.2.8. BioGX BV
11.2.9. Thermo Fisher Scientific Inc.
11.2.10. Megna Health Inc
11.2.11. CTK Biotech, Inc.
11.2.12. Biopanda Reagents Ltd
11.2.13. Other Prominent Players
Combo IVD Market By Sample Type-
Combo IVD Market By Channel-
Combo IVD Market By Test Type-
Combo IVD Market By Testing -
Combo IVD Market By End-User-
Combo IVD Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-